CC Small or few human trials. Promising, not proven. How we grade →Randomized crossover trial (MILES) · 14 adults about 70 years old
Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults
A Kulkarni, E Brutsaert, V Anghel, K Zhang, N Bloomgarden, M Pollak et al. Aging Cell. 2018.
- In plain language
- Six weeks of metformin lowered post-meal glucose and insulin and changed the activity of 647 genes in muscle and 146 in fat.
- Limits
- Tiny, short, gene activity rather than health outcomes.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Metformin as an aging drug: what the evidence shows, and why the TAME trial has not started
- Source
- doi.org/10.1111/acel.12723 · PubMed 29383869 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.